The Advanced Colorectal Cancer Meta-analysis Project.Meta-analysis of randomised trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol1994; 12: 960–9
3.
Anonymous.Efficacy of intravenous continuous infusion of 5-fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (in press)
4.
PazdurR, DouillardJ-Y, SkillingsJRMulticentre phase III study of 5-fluorouracil or UFT in combination with leucovorin in patients with metastatic colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1009
5.
TwelvesC, HarperP, Van CutsemE.A phase III trial (S014796) of Xeloda (capecitabine) in previously untreated advanced/metastatic colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1010
6.
CarmichaelJ, PopielaT, RadstoneDRandomised comparative study of ORZEL (oral uracil/Tegafur) plus leucovorin (IV) versus parenteral 5-fluorouracil plus leucovorin in patients with metastatic colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1015
7.
CoxJV, PazdurR, ThibaultAA phase II trial of Xeloda TM (capecitabine) in previously untreated advanced/metastatic colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1016
8.
Meta-analysis Group in Cancer.Re-appraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J Natl Cancer Inst1996; 88: 252–8
9.
KemenyMM, CohenA, HuangYRandomised study of hepatic arterial infusion and systemic versus systemic alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1011
10.
KemenyMM, AdakS, GrayBResults of the Intergroup (Eastern Co-operative Group (ECOG) and Southwest Oncology Group (SWOG) prospective randomised study of surgery alone versus continuous hepatic arterial infusion of FudR and continuous infusion of 5-fluorouracil after hepatic resection for colorectal liver metastases [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1012
11.
MaughanTS, JamesRD, KerrDOn behalf of the British MRC Colorectal Cancer Working Party. Preliminary results of a multicentre randomised trial comparing three chemotherapy regimens (de Gramont, Lokich, and Ralitrexed) in metastatic colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 1007
12.
CunninghamD, PyrhonenS, JamesRDRandomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet1998; 352: 1413–18
13.
SaltzL, LockerP, PirottaNWeekly irinotecan, leucovorin and fluorouracils superior to daily x 5 LV/FU in patients with previously untreated metastatic colorectal cancer [Abstract]. Proc Am Soc Clin Oncol1999; 18: 898
14.
De GramontA, VignoudJ, TournigantCOxaliplatin with high dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer1997; 32: 214–19
15.
MoertelCG, FlemingTH, MacDonaldJSLevamisole and fluorouracil for adjuvant treatment of resected colon cancer. N Engl J Med1990; 322: 352–8
16.
MidgleyRS, KerrDJ.Adjuvant treatment of colorectal cancer. Cancer Treatment Rev1997; 23: 135–52
17.
QUASAR Collaborative Group.Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomized trial. Lancet2000; 355: 1588–96
18.
Liver infusion Meta-analysis Group.Portal vein chemotherapy for colorectal cancer; a meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst1997; 89: 497–505
19.
MoertelCG.Chemotherapy for colorectal cancer. N Engl J Med1994; 330: 1136–43
20.
RiethmullerG, Schneider-GadickeE, SchmilokG.Randomised trial of monoclonal antibody for adjuvant treatment of resected Dukes C colorectal cancer. Lancet1994; 343: 1177–83
21.
HuberBE, AustinEA, GoodSSIn vivo anti-tumour activity of 5-fluorouracil on human CRC cells genetically modified to express cytosine deaminase. Cancer Res1993; 53: 4619–26
